Announcements Trials
Browse Landscape

Phase

Phase 3 8Phase 2 3Phase NA 2Phase 4 2Phase 1/2 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Classical hematology 3Sarcoma 2Plasma cell 1Other 1Gynecologic 1CNS 1

Conditions

Venous Thromboembolism 3Neoplasms 2Venous Thrombosis 1Thrombosis 1Pulmonary Embolism 1Obesity 1

Interventions

Cyclophosphamide 58Busulfan 47fludarabine phosphate 45Cyclosporine 34Mycophenolic Acid 31Whole-Body Irradiation 29Peripheral Blood Stem Cell Transplantation 29fludarabine 27Antilymphocyte Serum 27Tacrolimus 26Methotrexate 25Melphalan 25Filgrastim 20Radiotherapy 19Darbepoetin alfa 19Cytarabine 19Cord Blood Stem Cell Transplantation 18Epoetin Alfa 17Granulocyte Colony-Stimulating Factor 14Methylprednisolone 13thymoglobulin 10Thiotepa 9Etoposide 9Alemtuzumab 9eltrombopag 8Stem Cell Transplantation 8olaparib 7sargramostim 6hetrombopag 6Rituximab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Dalteparin × Classical hematology × Clear all
NCT03297359 2024-01-23

WAVe

Ottawa Hospital Research Institute

Phase 2 Terminated
92 enrolled
Classical hematologyOther

Neoplasms, Obesity, Venous Thromboembolism

NCT00952380 2019-04-16

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Pfizer

Phase 2 Completed
38 enrolled 30 charts
Classical hematology

Venous Thromboembolism

NCT01817257 2018-10-29

ALICAT

Cardiff University

Phase 2 Terminated
2 enrolled
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡